Keyword: cancer


Moderna and Immatics Collaborate on Cancer Therapies

18.09.2023 -

US vaccine maker Moderna and German biotechnology company Immatics agreed on a broad multi-platform research and development collaboration for novel cancer therapies...

Chemistry & Life Sciences

The Success Story of Biosimilars

13.09.2023 -

With their triumphant advance, biosimilars are also setting in motion the usual market mechanisms. Biopharma interest groups warn against the automatic substitution of...


Gilead Partners with Tentarix on Cancer and Inflammation Therapies

17.08.2023 -

Gilead Sciences and Tentarix Biotherapeutics established three multi-year collaborations using Tentarix’s proprietary Tentacles platform to discover and develop multi...


Bayer and Bicycle in Cancer Collaboration

16.05.2023 -

Bayer and UK biotech Bicycle Therapeutics have agreed to collaborate to develop and commercialize the latter’s radioconjugates for multiple oncology targets.


BioNTech and DualityBio Sign ADC Rights Deal

14.04.2023 -

German biotech and Covid vaccine maker BioNTech has sealed a major deal with Chinese biotech DualityBio to co-develop and commercialize two cancer antibody drug...


Plaintiffs Reject newest J&J Talc Litigation Offer

06.04.2023 -

Seeking to clear billions of dollars worth of litigation claiming that its iconic baby powder causes cancer, Johnson & Johnson has announced it is now prepared to offer a...


Pfizer Takes Seagen for $43 Billion

15.03.2023 -

Pfizer has agreed to acquire Seagen, a global biotech focused on developing cancer treatments, for $43 billion. The announcement comes just a couple of weeks after the...


Sumitovant Closes Myovant Purchase

15.03.2023 -

US biopharma Sumitovant – a wholly owned subsidiary of Japan’s Sumitomo Pharma – has closed its purchase of the remaining equity in Myovant Sciences, taking full control...